Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and ...

Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, primarily due to late-stage diagnosis ...

Researchers are calling for the application of locally driven strategies, supported by stronger regional evidence, to improve early cancer detection and precise care.

No one looks forward to a colonoscopy, but for the millions of Americans who refuse screening, a simple blood test could help catch colon cancer. For the first time, the American Cancer Society ...

Arrays of resonant nanoparticles, so-called metasurfaces, have been developed and demonstrated as the first generation of meta-operators. Unlike today’s electronic systems, the demonstrated compact, ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...

The test can screen for more than 50 types of cancer using a single blood sample, but doctors say it is important to understand both its benefits and limitations. Cancer remains one of the leading ...

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

Multi-category Personal Protective Equipment (PPE) non-compliance monitoring on construction sites remains challenging because visual cues for missing PPE often appear at multiple scales, particularly ...

For decades, cancer screening has relied on tests designed to detect one specific cancer at a time. Mammograms screen for breast cancer, colonoscopies look for colorectal cancer, and PSA tests help ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...